The October 30, 2015 Texas Register contained a proposed regulation published by the Texas Health and Human Services Commission (HHSC) that would replace pharmacy reimbursement under the Texas fee-for-service Medicaid program, currently based on Estimated Acquisition Cost, with Acquisition Cost based on NADAC, Long Term Care Acquisition Cost and Specialty Pharmacy Acquisition Cost.  In addition, the proposed regulation would repeal burdensome price reporting requirements for drug manufacturers, and instead require drug manufacturers to provide a Certificate of Information when a drug is added to the state Medicaid program and pricing updates only upon HHSC’s request. HHSC will hold a public hearing on this proposed regulation on November 23, and comments on the proposal may be submitted through November 30.  The regulations would become effective in the spring of 2016.